nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—CA9—hematologic cancer	0.266	1	CbGaD
Brinzolamide—CA14—Imatinib—hematologic cancer	0.0408	0.0798	CbGbCtD
Brinzolamide—CA6—Imatinib—hematologic cancer	0.0387	0.0758	CbGbCtD
Brinzolamide—CA14—Nilotinib—hematologic cancer	0.0371	0.0725	CbGbCtD
Brinzolamide—CA6—Nilotinib—hematologic cancer	0.0352	0.0689	CbGbCtD
Brinzolamide—CA7—Imatinib—hematologic cancer	0.0338	0.0661	CbGbCtD
Brinzolamide—CA7—Nilotinib—hematologic cancer	0.0307	0.06	CbGbCtD
Brinzolamide—CA9—Imatinib—hematologic cancer	0.029	0.0567	CbGbCtD
Brinzolamide—CA12—Imatinib—hematologic cancer	0.029	0.0567	CbGbCtD
Brinzolamide—CA1—Imatinib—hematologic cancer	0.0271	0.053	CbGbCtD
Brinzolamide—CA12—Nilotinib—hematologic cancer	0.0263	0.0515	CbGbCtD
Brinzolamide—CA9—Nilotinib—hematologic cancer	0.0263	0.0515	CbGbCtD
Brinzolamide—CA1—Nilotinib—hematologic cancer	0.0246	0.0482	CbGbCtD
Brinzolamide—CA2—Imatinib—hematologic cancer	0.0234	0.0458	CbGbCtD
Brinzolamide—CA4—Nilotinib—hematologic cancer	0.0232	0.0453	CbGbCtD
Brinzolamide—CA2—Nilotinib—hematologic cancer	0.0213	0.0417	CbGbCtD
Brinzolamide—CYP3A4—Bexarotene—hematologic cancer	0.00536	0.0105	CbGbCtD
Brinzolamide—CYP3A4—Lomustine—hematologic cancer	0.00498	0.00975	CbGbCtD
Brinzolamide—CYP3A4—Busulfan—hematologic cancer	0.00498	0.00975	CbGbCtD
Brinzolamide—CYP3A4—Thiotepa—hematologic cancer	0.00444	0.00869	CbGbCtD
Brinzolamide—CYP3A4—Methoxsalen—hematologic cancer	0.00345	0.00675	CbGbCtD
Brinzolamide—CYP3A4—Bortezomib—hematologic cancer	0.00328	0.00643	CbGbCtD
Brinzolamide—CYP3A4—Daunorubicin—hematologic cancer	0.00314	0.00615	CbGbCtD
Brinzolamide—CYP3A4—Cytarabine—hematologic cancer	0.00277	0.00542	CbGbCtD
Brinzolamide—CYP3A4—Teniposide—hematologic cancer	0.00273	0.00534	CbGbCtD
Brinzolamide—CYP3A4—Ifosfamide—hematologic cancer	0.00252	0.00493	CbGbCtD
Brinzolamide—CYP3A4—Imatinib—hematologic cancer	0.00241	0.00471	CbGbCtD
Brinzolamide—CYP3A4—Ruxolitinib—hematologic cancer	0.00227	0.00443	CbGbCtD
Brinzolamide—CYP3A4—Nilotinib—hematologic cancer	0.00219	0.00428	CbGbCtD
Brinzolamide—CYP3A4—Vinorelbine—hematologic cancer	0.00217	0.00424	CbGbCtD
Brinzolamide—Dorzolamide—CA9—hematologic cancer	0.00216	1	CrCbGaD
Brinzolamide—CYP3A4—Triamcinolone—hematologic cancer	0.00198	0.00388	CbGbCtD
Brinzolamide—CYP3A4—Dasatinib—hematologic cancer	0.00193	0.00378	CbGbCtD
Brinzolamide—CYP3A4—Mitoxantrone—hematologic cancer	0.00191	0.00373	CbGbCtD
Brinzolamide—CYP3A4—Betamethasone—hematologic cancer	0.0017	0.00333	CbGbCtD
Brinzolamide—CYP3A4—Prednisolone—hematologic cancer	0.00168	0.00328	CbGbCtD
Brinzolamide—CYP3A4—Prednisone—hematologic cancer	0.00159	0.0031	CbGbCtD
Brinzolamide—CYP3A4—Irinotecan—hematologic cancer	0.0015	0.00294	CbGbCtD
Brinzolamide—CYP3A4—Vinblastine—hematologic cancer	0.00134	0.00261	CbGbCtD
Brinzolamide—CYP3A4—Vincristine—hematologic cancer	0.00131	0.00257	CbGbCtD
Brinzolamide—CYP3A4—Etoposide—hematologic cancer	0.0012	0.00236	CbGbCtD
Brinzolamide—CYP3A4—Dexamethasone—hematologic cancer	0.00099	0.00194	CbGbCtD
Brinzolamide—CYP3A4—Doxorubicin—hematologic cancer	0.000821	0.00161	CbGbCtD
Brinzolamide—CA5B—hematopoietic system—hematologic cancer	0.000679	0.0765	CbGeAlD
Brinzolamide—CA1—hematopoietic system—hematologic cancer	0.0006	0.0675	CbGeAlD
Brinzolamide—CA9—testis—hematologic cancer	0.000561	0.0632	CbGeAlD
Brinzolamide—CA5B—gonad—hematologic cancer	0.000516	0.0581	CbGeAlD
Brinzolamide—CA5B—blood—hematologic cancer	0.00045	0.0507	CbGeAlD
Brinzolamide—CA12—lung—hematologic cancer	0.00044	0.0495	CbGeAlD
Brinzolamide—CA1—blood—hematologic cancer	0.000397	0.0447	CbGeAlD
Brinzolamide—CA5B—lung—hematologic cancer	0.000394	0.0444	CbGeAlD
Brinzolamide—CA2—hematopoietic system—hematologic cancer	0.000389	0.0438	CbGeAlD
Brinzolamide—CA1—bone marrow—hematologic cancer	0.000384	0.0433	CbGeAlD
Brinzolamide—CA5B—testis—hematologic cancer	0.000372	0.0419	CbGeAlD
Brinzolamide—CA1—lung—hematologic cancer	0.000348	0.0392	CbGeAlD
Brinzolamide—CA4—blood—hematologic cancer	0.000311	0.035	CbGeAlD
Brinzolamide—CA4—bone marrow—hematologic cancer	0.0003	0.0338	CbGeAlD
Brinzolamide—CA4—lung—hematologic cancer	0.000272	0.0307	CbGeAlD
Brinzolamide—CA5B—lymph node—hematologic cancer	0.00027	0.0304	CbGeAlD
Brinzolamide—CA2—blood—hematologic cancer	0.000257	0.029	CbGeAlD
Brinzolamide—CA4—testis—hematologic cancer	0.000257	0.0289	CbGeAlD
Brinzolamide—CYP3A4—hematopoietic system—hematologic cancer	0.000251	0.0282	CbGeAlD
Brinzolamide—CA2—bone marrow—hematologic cancer	0.000249	0.0281	CbGeAlD
Brinzolamide—CA1—lymph node—hematologic cancer	0.000238	0.0268	CbGeAlD
Brinzolamide—CA2—lung—hematologic cancer	0.000226	0.0254	CbGeAlD
Brinzolamide—CA2—testis—hematologic cancer	0.000213	0.024	CbGeAlD
Brinzolamide—CA4—lymph node—hematologic cancer	0.000186	0.021	CbGeAlD
Brinzolamide—CYP3A4—blood—hematologic cancer	0.000166	0.0187	CbGeAlD
Brinzolamide—CA2—lymph node—hematologic cancer	0.000154	0.0174	CbGeAlD
Brinzolamide—Erythema—Methotrexate—hematologic cancer	2.16e-05	0.000131	CcSEcCtD
Brinzolamide—Malnutrition—Methotrexate—hematologic cancer	2.16e-05	0.000131	CcSEcCtD
Brinzolamide—Headache—Gemcitabine—hematologic cancer	2.16e-05	0.000131	CcSEcCtD
Brinzolamide—Nausea—Vincristine—hematologic cancer	2.15e-05	0.000131	CcSEcCtD
Brinzolamide—Cardiac disorder—Epirubicin—hematologic cancer	2.15e-05	0.000131	CcSEcCtD
Brinzolamide—Rhinitis—Doxorubicin—hematologic cancer	2.15e-05	0.000131	CcSEcCtD
Brinzolamide—Hypersensitivity—Prednisolone—hematologic cancer	2.13e-05	0.00013	CcSEcCtD
Brinzolamide—Hypoaesthesia—Doxorubicin—hematologic cancer	2.13e-05	0.00013	CcSEcCtD
Brinzolamide—Pharyngitis—Doxorubicin—hematologic cancer	2.13e-05	0.000129	CcSEcCtD
Brinzolamide—Dyspepsia—Dexamethasone—hematologic cancer	2.13e-05	0.000129	CcSEcCtD
Brinzolamide—Dyspepsia—Betamethasone—hematologic cancer	2.13e-05	0.000129	CcSEcCtD
Brinzolamide—Urinary tract disorder—Doxorubicin—hematologic cancer	2.12e-05	0.000129	CcSEcCtD
Brinzolamide—Urticaria—Triamcinolone—hematologic cancer	2.12e-05	0.000129	CcSEcCtD
Brinzolamide—Oedema peripheral—Doxorubicin—hematologic cancer	2.11e-05	0.000128	CcSEcCtD
Brinzolamide—Dysgeusia—Methotrexate—hematologic cancer	2.11e-05	0.000128	CcSEcCtD
Brinzolamide—Asthenia—Etoposide—hematologic cancer	2.11e-05	0.000128	CcSEcCtD
Brinzolamide—Connective tissue disorder—Doxorubicin—hematologic cancer	2.11e-05	0.000128	CcSEcCtD
Brinzolamide—Angiopathy—Epirubicin—hematologic cancer	2.1e-05	0.000128	CcSEcCtD
Brinzolamide—Urethral disorder—Doxorubicin—hematologic cancer	2.1e-05	0.000128	CcSEcCtD
Brinzolamide—Decreased appetite—Betamethasone—hematologic cancer	2.1e-05	0.000128	CcSEcCtD
Brinzolamide—Decreased appetite—Dexamethasone—hematologic cancer	2.1e-05	0.000128	CcSEcCtD
Brinzolamide—Nausea—Mitoxantrone—hematologic cancer	2.1e-05	0.000127	CcSEcCtD
Brinzolamide—Nausea—Irinotecan—hematologic cancer	2.1e-05	0.000127	CcSEcCtD
Brinzolamide—Immune system disorder—Epirubicin—hematologic cancer	2.09e-05	0.000127	CcSEcCtD
Brinzolamide—Infection—Prednisone—hematologic cancer	2.09e-05	0.000127	CcSEcCtD
Brinzolamide—Mediastinal disorder—Epirubicin—hematologic cancer	2.09e-05	0.000127	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Dexamethasone—hematologic cancer	2.09e-05	0.000127	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.09e-05	0.000127	CcSEcCtD
Brinzolamide—Back pain—Methotrexate—hematologic cancer	2.09e-05	0.000127	CcSEcCtD
Brinzolamide—Fatigue—Betamethasone—hematologic cancer	2.08e-05	0.000127	CcSEcCtD
Brinzolamide—Fatigue—Dexamethasone—hematologic cancer	2.08e-05	0.000127	CcSEcCtD
Brinzolamide—Pruritus—Etoposide—hematologic cancer	2.08e-05	0.000126	CcSEcCtD
Brinzolamide—Arrhythmia—Epirubicin—hematologic cancer	2.07e-05	0.000126	CcSEcCtD
Brinzolamide—Pain—Dexamethasone—hematologic cancer	2.07e-05	0.000126	CcSEcCtD
Brinzolamide—Pain—Betamethasone—hematologic cancer	2.07e-05	0.000126	CcSEcCtD
Brinzolamide—Visual impairment—Doxorubicin—hematologic cancer	2.07e-05	0.000126	CcSEcCtD
Brinzolamide—Nervous system disorder—Prednisone—hematologic cancer	2.06e-05	0.000125	CcSEcCtD
Brinzolamide—Tachycardia—Prednisone—hematologic cancer	2.05e-05	0.000125	CcSEcCtD
Brinzolamide—Alopecia—Epirubicin—hematologic cancer	2.05e-05	0.000124	CcSEcCtD
Brinzolamide—Skin disorder—Prednisone—hematologic cancer	2.05e-05	0.000124	CcSEcCtD
Brinzolamide—Nausea—Gemcitabine—hematologic cancer	2.04e-05	0.000124	CcSEcCtD
Brinzolamide—Vomiting—Cisplatin—hematologic cancer	2.04e-05	0.000124	CcSEcCtD
Brinzolamide—Vision blurred—Methotrexate—hematologic cancer	2.03e-05	0.000123	CcSEcCtD
Brinzolamide—Mental disorder—Epirubicin—hematologic cancer	2.03e-05	0.000123	CcSEcCtD
Brinzolamide—Rash—Cisplatin—hematologic cancer	2.02e-05	0.000123	CcSEcCtD
Brinzolamide—Dermatitis—Cisplatin—hematologic cancer	2.02e-05	0.000123	CcSEcCtD
Brinzolamide—Malnutrition—Epirubicin—hematologic cancer	2.02e-05	0.000123	CcSEcCtD
Brinzolamide—Erythema—Epirubicin—hematologic cancer	2.02e-05	0.000123	CcSEcCtD
Brinzolamide—Diarrhoea—Etoposide—hematologic cancer	2.01e-05	0.000122	CcSEcCtD
Brinzolamide—Eye disorder—Doxorubicin—hematologic cancer	2e-05	0.000122	CcSEcCtD
Brinzolamide—Ill-defined disorder—Methotrexate—hematologic cancer	2e-05	0.000121	CcSEcCtD
Brinzolamide—Tinnitus—Doxorubicin—hematologic cancer	2e-05	0.000121	CcSEcCtD
Brinzolamide—Feeling abnormal—Dexamethasone—hematologic cancer	1.99e-05	0.000121	CcSEcCtD
Brinzolamide—Feeling abnormal—Betamethasone—hematologic cancer	1.99e-05	0.000121	CcSEcCtD
Brinzolamide—Cardiac disorder—Doxorubicin—hematologic cancer	1.99e-05	0.000121	CcSEcCtD
Brinzolamide—Flatulence—Epirubicin—hematologic cancer	1.99e-05	0.000121	CcSEcCtD
Brinzolamide—Tension—Epirubicin—hematologic cancer	1.98e-05	0.00012	CcSEcCtD
Brinzolamide—Dysgeusia—Epirubicin—hematologic cancer	1.98e-05	0.00012	CcSEcCtD
Brinzolamide—Hypersensitivity—Triamcinolone—hematologic cancer	1.96e-05	0.000119	CcSEcCtD
Brinzolamide—Nervousness—Epirubicin—hematologic cancer	1.96e-05	0.000119	CcSEcCtD
Brinzolamide—Back pain—Epirubicin—hematologic cancer	1.95e-05	0.000119	CcSEcCtD
Brinzolamide—Angiopathy—Doxorubicin—hematologic cancer	1.95e-05	0.000118	CcSEcCtD
Brinzolamide—Malaise—Methotrexate—hematologic cancer	1.94e-05	0.000118	CcSEcCtD
Brinzolamide—Dizziness—Etoposide—hematologic cancer	1.94e-05	0.000118	CcSEcCtD
Brinzolamide—Muscle spasms—Epirubicin—hematologic cancer	1.94e-05	0.000118	CcSEcCtD
Brinzolamide—Immune system disorder—Doxorubicin—hematologic cancer	1.94e-05	0.000118	CcSEcCtD
Brinzolamide—Vertigo—Methotrexate—hematologic cancer	1.94e-05	0.000118	CcSEcCtD
Brinzolamide—Mediastinal disorder—Doxorubicin—hematologic cancer	1.93e-05	0.000117	CcSEcCtD
Brinzolamide—Urticaria—Dexamethasone—hematologic cancer	1.92e-05	0.000117	CcSEcCtD
Brinzolamide—Urticaria—Betamethasone—hematologic cancer	1.92e-05	0.000117	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.92e-05	0.000117	CcSEcCtD
Brinzolamide—Dizziness—Prednisolone—hematologic cancer	1.92e-05	0.000116	CcSEcCtD
Brinzolamide—Arrhythmia—Doxorubicin—hematologic cancer	1.92e-05	0.000116	CcSEcCtD
Brinzolamide—Asthenia—Triamcinolone—hematologic cancer	1.91e-05	0.000116	CcSEcCtD
Brinzolamide—Nausea—Cisplatin—hematologic cancer	1.9e-05	0.000116	CcSEcCtD
Brinzolamide—Insomnia—Prednisone—hematologic cancer	1.9e-05	0.000116	CcSEcCtD
Brinzolamide—Vision blurred—Epirubicin—hematologic cancer	1.9e-05	0.000115	CcSEcCtD
Brinzolamide—Alopecia—Doxorubicin—hematologic cancer	1.9e-05	0.000115	CcSEcCtD
Brinzolamide—Paraesthesia—Prednisone—hematologic cancer	1.89e-05	0.000115	CcSEcCtD
Brinzolamide—Pruritus—Triamcinolone—hematologic cancer	1.89e-05	0.000114	CcSEcCtD
Brinzolamide—Cough—Methotrexate—hematologic cancer	1.88e-05	0.000114	CcSEcCtD
Brinzolamide—Mental disorder—Doxorubicin—hematologic cancer	1.88e-05	0.000114	CcSEcCtD
Brinzolamide—Ill-defined disorder—Epirubicin—hematologic cancer	1.87e-05	0.000114	CcSEcCtD
Brinzolamide—Vomiting—Etoposide—hematologic cancer	1.87e-05	0.000113	CcSEcCtD
Brinzolamide—Malnutrition—Doxorubicin—hematologic cancer	1.87e-05	0.000113	CcSEcCtD
Brinzolamide—Erythema—Doxorubicin—hematologic cancer	1.87e-05	0.000113	CcSEcCtD
Brinzolamide—Agitation—Epirubicin—hematologic cancer	1.85e-05	0.000113	CcSEcCtD
Brinzolamide—Dyspepsia—Prednisone—hematologic cancer	1.85e-05	0.000113	CcSEcCtD
Brinzolamide—Rash—Etoposide—hematologic cancer	1.85e-05	0.000112	CcSEcCtD
Brinzolamide—Dermatitis—Etoposide—hematologic cancer	1.85e-05	0.000112	CcSEcCtD
Brinzolamide—Headache—Etoposide—hematologic cancer	1.84e-05	0.000112	CcSEcCtD
Brinzolamide—Flatulence—Doxorubicin—hematologic cancer	1.84e-05	0.000112	CcSEcCtD
Brinzolamide—Chest pain—Methotrexate—hematologic cancer	1.84e-05	0.000111	CcSEcCtD
Brinzolamide—Arthralgia—Methotrexate—hematologic cancer	1.84e-05	0.000111	CcSEcCtD
Brinzolamide—Myalgia—Methotrexate—hematologic cancer	1.84e-05	0.000111	CcSEcCtD
Brinzolamide—Tension—Doxorubicin—hematologic cancer	1.83e-05	0.000111	CcSEcCtD
Brinzolamide—Decreased appetite—Prednisone—hematologic cancer	1.83e-05	0.000111	CcSEcCtD
Brinzolamide—Dysgeusia—Doxorubicin—hematologic cancer	1.83e-05	0.000111	CcSEcCtD
Brinzolamide—Rash—Prednisolone—hematologic cancer	1.83e-05	0.000111	CcSEcCtD
Brinzolamide—Dermatitis—Prednisolone—hematologic cancer	1.83e-05	0.000111	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.82e-05	0.000111	CcSEcCtD
Brinzolamide—Malaise—Epirubicin—hematologic cancer	1.82e-05	0.000111	CcSEcCtD
Brinzolamide—Fatigue—Prednisone—hematologic cancer	1.82e-05	0.00011	CcSEcCtD
Brinzolamide—Headache—Prednisolone—hematologic cancer	1.82e-05	0.00011	CcSEcCtD
Brinzolamide—Discomfort—Methotrexate—hematologic cancer	1.81e-05	0.00011	CcSEcCtD
Brinzolamide—Nervousness—Doxorubicin—hematologic cancer	1.81e-05	0.00011	CcSEcCtD
Brinzolamide—Vertigo—Epirubicin—hematologic cancer	1.81e-05	0.00011	CcSEcCtD
Brinzolamide—Back pain—Doxorubicin—hematologic cancer	1.81e-05	0.00011	CcSEcCtD
Brinzolamide—Muscle spasms—Doxorubicin—hematologic cancer	1.79e-05	0.000109	CcSEcCtD
Brinzolamide—Palpitations—Epirubicin—hematologic cancer	1.78e-05	0.000108	CcSEcCtD
Brinzolamide—Dizziness—Triamcinolone—hematologic cancer	1.76e-05	0.000107	CcSEcCtD
Brinzolamide—Cough—Epirubicin—hematologic cancer	1.76e-05	0.000107	CcSEcCtD
Brinzolamide—Vision blurred—Doxorubicin—hematologic cancer	1.76e-05	0.000107	CcSEcCtD
Brinzolamide—Infection—Methotrexate—hematologic cancer	1.75e-05	0.000106	CcSEcCtD
Brinzolamide—Nausea—Etoposide—hematologic cancer	1.74e-05	0.000106	CcSEcCtD
Brinzolamide—Hypertension—Epirubicin—hematologic cancer	1.74e-05	0.000106	CcSEcCtD
Brinzolamide—Feeling abnormal—Prednisone—hematologic cancer	1.73e-05	0.000105	CcSEcCtD
Brinzolamide—Asthenia—Dexamethasone—hematologic cancer	1.73e-05	0.000105	CcSEcCtD
Brinzolamide—Asthenia—Betamethasone—hematologic cancer	1.73e-05	0.000105	CcSEcCtD
Brinzolamide—Ill-defined disorder—Doxorubicin—hematologic cancer	1.73e-05	0.000105	CcSEcCtD
Brinzolamide—Nervous system disorder—Methotrexate—hematologic cancer	1.73e-05	0.000105	CcSEcCtD
Brinzolamide—Nausea—Prednisolone—hematologic cancer	1.72e-05	0.000105	CcSEcCtD
Brinzolamide—Chest pain—Epirubicin—hematologic cancer	1.72e-05	0.000104	CcSEcCtD
Brinzolamide—Myalgia—Epirubicin—hematologic cancer	1.72e-05	0.000104	CcSEcCtD
Brinzolamide—Arthralgia—Epirubicin—hematologic cancer	1.72e-05	0.000104	CcSEcCtD
Brinzolamide—Agitation—Doxorubicin—hematologic cancer	1.72e-05	0.000104	CcSEcCtD
Brinzolamide—CA2—Metabolism—GSTT1—hematologic cancer	1.71e-05	0.00036	CbGpPWpGaD
Brinzolamide—Pruritus—Betamethasone—hematologic cancer	1.71e-05	0.000104	CcSEcCtD
Brinzolamide—Pruritus—Dexamethasone—hematologic cancer	1.71e-05	0.000104	CcSEcCtD
Brinzolamide—Skin disorder—Methotrexate—hematologic cancer	1.71e-05	0.000104	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.71e-05	0.000104	CcSEcCtD
Brinzolamide—CA9—Metabolism—CRABP1—hematologic cancer	1.7e-05	0.000358	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—SLC22A1—hematologic cancer	1.7e-05	0.000358	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—ABCB1—hematologic cancer	1.7e-05	0.000357	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—ABCB1—hematologic cancer	1.7e-05	0.000357	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—UGT1A1—hematologic cancer	1.7e-05	0.000357	CbGpPWpGaD
Brinzolamide—Discomfort—Epirubicin—hematologic cancer	1.7e-05	0.000103	CcSEcCtD
Brinzolamide—CA9—Cellular responses to stress—VEGFA—hematologic cancer	1.7e-05	0.000356	CbGpPWpGaD
Brinzolamide—Vomiting—Triamcinolone—hematologic cancer	1.69e-05	0.000103	CcSEcCtD
Brinzolamide—CA14—Metabolism—NCOR1—hematologic cancer	1.69e-05	0.000356	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ENO2—hematologic cancer	1.69e-05	0.000356	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—GSTM1—hematologic cancer	1.69e-05	0.000356	CbGpPWpGaD
Brinzolamide—Malaise—Doxorubicin—hematologic cancer	1.68e-05	0.000102	CcSEcCtD
Brinzolamide—Rash—Triamcinolone—hematologic cancer	1.68e-05	0.000102	CcSEcCtD
Brinzolamide—Dry mouth—Epirubicin—hematologic cancer	1.68e-05	0.000102	CcSEcCtD
Brinzolamide—CA9—Cellular responses to stress—STAT3—hematologic cancer	1.68e-05	0.000353	CbGpPWpGaD
Brinzolamide—Dermatitis—Triamcinolone—hematologic cancer	1.68e-05	0.000102	CcSEcCtD
Brinzolamide—Vertigo—Doxorubicin—hematologic cancer	1.68e-05	0.000102	CcSEcCtD
Brinzolamide—CA5B—Metabolism—GSTP1—hematologic cancer	1.68e-05	0.000352	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—GSTP1—hematologic cancer	1.68e-05	0.000352	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—SDC1—hematologic cancer	1.67e-05	0.000352	CbGpPWpGaD
Brinzolamide—Urticaria—Prednisone—hematologic cancer	1.67e-05	0.000102	CcSEcCtD
Brinzolamide—Headache—Triamcinolone—hematologic cancer	1.67e-05	0.000101	CcSEcCtD
Brinzolamide—CA9—Metabolism—ALOX5—hematologic cancer	1.66e-05	0.000349	CbGpPWpGaD
Brinzolamide—Diarrhoea—Dexamethasone—hematologic cancer	1.65e-05	0.0001	CcSEcCtD
Brinzolamide—Diarrhoea—Betamethasone—hematologic cancer	1.65e-05	0.0001	CcSEcCtD
Brinzolamide—CA6—Metabolism—GSTM1—hematologic cancer	1.65e-05	0.000347	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—NCOR1—hematologic cancer	1.65e-05	0.000347	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—GSTM1—hematologic cancer	1.65e-05	0.000347	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—NCOR1—hematologic cancer	1.65e-05	0.000347	CbGpPWpGaD
Brinzolamide—Palpitations—Doxorubicin—hematologic cancer	1.65e-05	0.0001	CcSEcCtD
Brinzolamide—Hypotension—Methotrexate—hematologic cancer	1.64e-05	9.99e-05	CcSEcCtD
Brinzolamide—CA1—Metabolism—GSTT1—hematologic cancer	1.64e-05	0.000345	CbGpPWpGaD
Brinzolamide—Infection—Epirubicin—hematologic cancer	1.64e-05	9.94e-05	CcSEcCtD
Brinzolamide—Cough—Doxorubicin—hematologic cancer	1.63e-05	9.89e-05	CcSEcCtD
Brinzolamide—Nervous system disorder—Epirubicin—hematologic cancer	1.61e-05	9.81e-05	CcSEcCtD
Brinzolamide—Hypertension—Doxorubicin—hematologic cancer	1.61e-05	9.79e-05	CcSEcCtD
Brinzolamide—CA9—Metabolism—NUP98—hematologic cancer	1.61e-05	0.000338	CbGpPWpGaD
Brinzolamide—Tachycardia—Epirubicin—hematologic cancer	1.61e-05	9.76e-05	CcSEcCtD
Brinzolamide—CA1—Metabolism—SDC1—hematologic cancer	1.61e-05	0.000337	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—MAPK3—hematologic cancer	1.6e-05	0.000337	CbGpPWpGaD
Brinzolamide—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.6e-05	9.74e-05	CcSEcCtD
Brinzolamide—Skin disorder—Epirubicin—hematologic cancer	1.6e-05	9.71e-05	CcSEcCtD
Brinzolamide—Dizziness—Betamethasone—hematologic cancer	1.6e-05	9.71e-05	CcSEcCtD
Brinzolamide—Dizziness—Dexamethasone—hematologic cancer	1.6e-05	9.71e-05	CcSEcCtD
Brinzolamide—Insomnia—Methotrexate—hematologic cancer	1.59e-05	9.67e-05	CcSEcCtD
Brinzolamide—Arthralgia—Doxorubicin—hematologic cancer	1.59e-05	9.65e-05	CcSEcCtD
Brinzolamide—Chest pain—Doxorubicin—hematologic cancer	1.59e-05	9.65e-05	CcSEcCtD
Brinzolamide—Myalgia—Doxorubicin—hematologic cancer	1.59e-05	9.65e-05	CcSEcCtD
Brinzolamide—CA5B—Metabolism—ABCB1—hematologic cancer	1.59e-05	0.000333	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—ABCB1—hematologic cancer	1.59e-05	0.000333	CbGpPWpGaD
Brinzolamide—Nausea—Triamcinolone—hematologic cancer	1.58e-05	9.61e-05	CcSEcCtD
Brinzolamide—Paraesthesia—Methotrexate—hematologic cancer	1.58e-05	9.6e-05	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.58e-05	9.59e-05	CcSEcCtD
Brinzolamide—Discomfort—Doxorubicin—hematologic cancer	1.57e-05	9.54e-05	CcSEcCtD
Brinzolamide—Dyspnoea—Methotrexate—hematologic cancer	1.57e-05	9.53e-05	CcSEcCtD
Brinzolamide—Somnolence—Methotrexate—hematologic cancer	1.56e-05	9.5e-05	CcSEcCtD
Brinzolamide—CA9—Metabolism—ADCY7—hematologic cancer	1.56e-05	0.000328	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—NCOA3—hematologic cancer	1.56e-05	0.000328	CbGpPWpGaD
Brinzolamide—Dry mouth—Doxorubicin—hematologic cancer	1.55e-05	9.44e-05	CcSEcCtD
Brinzolamide—CA12—Metabolism—GSTP1—hematologic cancer	1.55e-05	0.000326	CbGpPWpGaD
Brinzolamide—Hypersensitivity—Prednisone—hematologic cancer	1.55e-05	9.42e-05	CcSEcCtD
Brinzolamide—CA9—Metabolism—NUP214—hematologic cancer	1.55e-05	0.000326	CbGpPWpGaD
Brinzolamide—Dyspepsia—Methotrexate—hematologic cancer	1.55e-05	9.41e-05	CcSEcCtD
Brinzolamide—CA5B—Metabolism—NCOR1—hematologic cancer	1.54e-05	0.000324	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—GSTM1—hematologic cancer	1.54e-05	0.000324	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—NCOR1—hematologic cancer	1.54e-05	0.000324	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—GSTM1—hematologic cancer	1.54e-05	0.000324	CbGpPWpGaD
Brinzolamide—Hypotension—Epirubicin—hematologic cancer	1.54e-05	9.35e-05	CcSEcCtD
Brinzolamide—Vomiting—Dexamethasone—hematologic cancer	1.54e-05	9.34e-05	CcSEcCtD
Brinzolamide—Vomiting—Betamethasone—hematologic cancer	1.54e-05	9.34e-05	CcSEcCtD
Brinzolamide—Decreased appetite—Methotrexate—hematologic cancer	1.53e-05	9.29e-05	CcSEcCtD
Brinzolamide—Rash—Dexamethasone—hematologic cancer	1.52e-05	9.26e-05	CcSEcCtD
Brinzolamide—Rash—Betamethasone—hematologic cancer	1.52e-05	9.26e-05	CcSEcCtD
Brinzolamide—Dermatitis—Betamethasone—hematologic cancer	1.52e-05	9.25e-05	CcSEcCtD
Brinzolamide—Dermatitis—Dexamethasone—hematologic cancer	1.52e-05	9.25e-05	CcSEcCtD
Brinzolamide—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	1.52e-05	0.000319	CbGpPWpGaD
Brinzolamide—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.52e-05	9.23e-05	CcSEcCtD
Brinzolamide—CA9—Metabolism—ABCG2—hematologic cancer	1.52e-05	0.000319	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—MTR—hematologic cancer	1.52e-05	0.000319	CbGpPWpGaD
Brinzolamide—Fatigue—Methotrexate—hematologic cancer	1.52e-05	9.21e-05	CcSEcCtD
Brinzolamide—Headache—Dexamethasone—hematologic cancer	1.51e-05	9.2e-05	CcSEcCtD
Brinzolamide—Headache—Betamethasone—hematologic cancer	1.51e-05	9.2e-05	CcSEcCtD
Brinzolamide—Infection—Doxorubicin—hematologic cancer	1.51e-05	9.19e-05	CcSEcCtD
Brinzolamide—Asthenia—Prednisone—hematologic cancer	1.51e-05	9.17e-05	CcSEcCtD
Brinzolamide—Pain—Methotrexate—hematologic cancer	1.5e-05	9.14e-05	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.5e-05	9.11e-05	CcSEcCtD
Brinzolamide—CA14—Metabolism—MTHFR—hematologic cancer	1.5e-05	0.000314	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—MTR—hematologic cancer	1.49e-05	0.000314	CbGpPWpGaD
Brinzolamide—Nervous system disorder—Doxorubicin—hematologic cancer	1.49e-05	9.07e-05	CcSEcCtD
Brinzolamide—Pruritus—Prednisone—hematologic cancer	1.49e-05	9.05e-05	CcSEcCtD
Brinzolamide—Insomnia—Epirubicin—hematologic cancer	1.49e-05	9.05e-05	CcSEcCtD
Brinzolamide—CA9—Metabolism—ENO2—hematologic cancer	1.49e-05	0.000313	CbGpPWpGaD
Brinzolamide—Tachycardia—Doxorubicin—hematologic cancer	1.49e-05	9.03e-05	CcSEcCtD
Brinzolamide—CA4—Metabolism—CD44—hematologic cancer	1.49e-05	0.000312	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—NQO1—hematologic cancer	1.49e-05	0.000312	CbGpPWpGaD
Brinzolamide—Skin disorder—Doxorubicin—hematologic cancer	1.48e-05	8.99e-05	CcSEcCtD
Brinzolamide—Paraesthesia—Epirubicin—hematologic cancer	1.48e-05	8.98e-05	CcSEcCtD
Brinzolamide—CA12—Metabolism—ABCB1—hematologic cancer	1.47e-05	0.000309	CbGpPWpGaD
Brinzolamide—Dyspnoea—Epirubicin—hematologic cancer	1.47e-05	8.92e-05	CcSEcCtD
Brinzolamide—Somnolence—Epirubicin—hematologic cancer	1.46e-05	8.89e-05	CcSEcCtD
Brinzolamide—CA5A—Metabolism—MTHFR—hematologic cancer	1.46e-05	0.000306	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—MTHFR—hematologic cancer	1.46e-05	0.000306	CbGpPWpGaD
Brinzolamide—Feeling abnormal—Methotrexate—hematologic cancer	1.45e-05	8.81e-05	CcSEcCtD
Brinzolamide—Dyspepsia—Epirubicin—hematologic cancer	1.45e-05	8.8e-05	CcSEcCtD
Brinzolamide—CA9—Metabolism—GSTT1—hematologic cancer	1.44e-05	0.000303	CbGpPWpGaD
Brinzolamide—Diarrhoea—Prednisone—hematologic cancer	1.44e-05	8.75e-05	CcSEcCtD
Brinzolamide—Nausea—Dexamethasone—hematologic cancer	1.44e-05	8.72e-05	CcSEcCtD
Brinzolamide—Nausea—Betamethasone—hematologic cancer	1.44e-05	8.72e-05	CcSEcCtD
Brinzolamide—Decreased appetite—Epirubicin—hematologic cancer	1.43e-05	8.69e-05	CcSEcCtD
Brinzolamide—CA12—Metabolism—GSTM1—hematologic cancer	1.43e-05	0.0003	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—NCOR1—hematologic cancer	1.43e-05	0.0003	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—NQO1—hematologic cancer	1.42e-05	0.000299	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CD44—hematologic cancer	1.42e-05	0.000299	CbGpPWpGaD
Brinzolamide—Hypotension—Doxorubicin—hematologic cancer	1.42e-05	8.65e-05	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.42e-05	8.63e-05	CcSEcCtD
Brinzolamide—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	1.42e-05	0.000299	CbGpPWpGaD
Brinzolamide—Fatigue—Epirubicin—hematologic cancer	1.42e-05	8.62e-05	CcSEcCtD
Brinzolamide—CA9—Metabolism—SDC1—hematologic cancer	1.41e-05	0.000297	CbGpPWpGaD
Brinzolamide—Pain—Epirubicin—hematologic cancer	1.41e-05	8.55e-05	CcSEcCtD
Brinzolamide—CA4—Metabolism—CYCS—hematologic cancer	1.41e-05	0.000295	CbGpPWpGaD
Brinzolamide—Urticaria—Methotrexate—hematologic cancer	1.4e-05	8.49e-05	CcSEcCtD
Brinzolamide—CA4—Metabolism—HSP90AA1—hematologic cancer	1.4e-05	0.000293	CbGpPWpGaD
Brinzolamide—Dizziness—Prednisone—hematologic cancer	1.39e-05	8.46e-05	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.39e-05	8.43e-05	CcSEcCtD
Brinzolamide—Insomnia—Doxorubicin—hematologic cancer	1.38e-05	8.37e-05	CcSEcCtD
Brinzolamide—Paraesthesia—Doxorubicin—hematologic cancer	1.37e-05	8.31e-05	CcSEcCtD
Brinzolamide—CA1—Metabolism—NQO1—hematologic cancer	1.36e-05	0.000287	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CD44—hematologic cancer	1.36e-05	0.000287	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—MTHFR—hematologic cancer	1.36e-05	0.000286	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—MTHFR—hematologic cancer	1.36e-05	0.000286	CbGpPWpGaD
Brinzolamide—Dyspnoea—Doxorubicin—hematologic cancer	1.36e-05	8.25e-05	CcSEcCtD
Brinzolamide—Feeling abnormal—Epirubicin—hematologic cancer	1.36e-05	8.24e-05	CcSEcCtD
Brinzolamide—Somnolence—Doxorubicin—hematologic cancer	1.35e-05	8.23e-05	CcSEcCtD
Brinzolamide—CA2—Metabolism—CYCS—hematologic cancer	1.35e-05	0.000283	CbGpPWpGaD
Brinzolamide—Dyspepsia—Doxorubicin—hematologic cancer	1.34e-05	8.15e-05	CcSEcCtD
Brinzolamide—Vomiting—Prednisone—hematologic cancer	1.34e-05	8.13e-05	CcSEcCtD
Brinzolamide—CA2—Metabolism—HSP90AA1—hematologic cancer	1.34e-05	0.000281	CbGpPWpGaD
Brinzolamide—Rash—Prednisone—hematologic cancer	1.33e-05	8.06e-05	CcSEcCtD
Brinzolamide—Dermatitis—Prednisone—hematologic cancer	1.33e-05	8.06e-05	CcSEcCtD
Brinzolamide—Decreased appetite—Doxorubicin—hematologic cancer	1.32e-05	8.04e-05	CcSEcCtD
Brinzolamide—Headache—Prednisone—hematologic cancer	1.32e-05	8.01e-05	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.32e-05	7.99e-05	CcSEcCtD
Brinzolamide—Fatigue—Doxorubicin—hematologic cancer	1.31e-05	7.98e-05	CcSEcCtD
Brinzolamide—Urticaria—Epirubicin—hematologic cancer	1.31e-05	7.94e-05	CcSEcCtD
Brinzolamide—Pain—Doxorubicin—hematologic cancer	1.3e-05	7.91e-05	CcSEcCtD
Brinzolamide—Hypersensitivity—Methotrexate—hematologic cancer	1.3e-05	7.87e-05	CcSEcCtD
Brinzolamide—CA1—Metabolism—CYCS—hematologic cancer	1.29e-05	0.000271	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—HSP90AA1—hematologic cancer	1.28e-05	0.00027	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—TP53—hematologic cancer	1.28e-05	0.000269	CbGpPWpGaD
Brinzolamide—Asthenia—Methotrexate—hematologic cancer	1.26e-05	7.67e-05	CcSEcCtD
Brinzolamide—CA12—Metabolism—MTHFR—hematologic cancer	1.26e-05	0.000265	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PIK3CG—hematologic cancer	1.26e-05	0.000264	CbGpPWpGaD
Brinzolamide—Feeling abnormal—Doxorubicin—hematologic cancer	1.26e-05	7.63e-05	CcSEcCtD
Brinzolamide—Nausea—Prednisone—hematologic cancer	1.25e-05	7.6e-05	CcSEcCtD
Brinzolamide—Pruritus—Methotrexate—hematologic cancer	1.24e-05	7.56e-05	CcSEcCtD
Brinzolamide—CA4—Metabolism—GSTP1—hematologic cancer	1.24e-05	0.00026	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PIK3CG—hematologic cancer	1.23e-05	0.000257	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3CG—hematologic cancer	1.23e-05	0.000257	CbGpPWpGaD
Brinzolamide—Hypersensitivity—Epirubicin—hematologic cancer	1.21e-05	7.37e-05	CcSEcCtD
Brinzolamide—Urticaria—Doxorubicin—hematologic cancer	1.21e-05	7.35e-05	CcSEcCtD
Brinzolamide—Diarrhoea—Methotrexate—hematologic cancer	1.2e-05	7.31e-05	CcSEcCtD
Brinzolamide—CA9—Metabolism—CD44—hematologic cancer	1.2e-05	0.000252	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—NQO1—hematologic cancer	1.2e-05	0.000252	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GSTP1—hematologic cancer	1.19e-05	0.000249	CbGpPWpGaD
Brinzolamide—Asthenia—Epirubicin—hematologic cancer	1.18e-05	7.18e-05	CcSEcCtD
Brinzolamide—CA9—Cellular responses to stress—IL6—hematologic cancer	1.17e-05	0.000246	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ABCB1—hematologic cancer	1.17e-05	0.000246	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—CREBBP—hematologic cancer	1.17e-05	0.000245	CbGpPWpGaD
Brinzolamide—Pruritus—Epirubicin—hematologic cancer	1.16e-05	7.08e-05	CcSEcCtD
Brinzolamide—Dizziness—Methotrexate—hematologic cancer	1.16e-05	7.07e-05	CcSEcCtD
Brinzolamide—CA7—Metabolism—PIK3CG—hematologic cancer	1.14e-05	0.00024	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3CG—hematologic cancer	1.14e-05	0.00024	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GSTP1—hematologic cancer	1.14e-05	0.000239	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GSTM1—hematologic cancer	1.14e-05	0.000239	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—NCOR1—hematologic cancer	1.14e-05	0.000239	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—CREBBP—hematologic cancer	1.14e-05	0.000239	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—CREBBP—hematologic cancer	1.14e-05	0.000239	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYCS—hematologic cancer	1.14e-05	0.000239	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—HSP90AA1—hematologic cancer	1.13e-05	0.000237	CbGpPWpGaD
Brinzolamide—Diarrhoea—Epirubicin—hematologic cancer	1.13e-05	6.84e-05	CcSEcCtD
Brinzolamide—CA2—Metabolism—ABCB1—hematologic cancer	1.12e-05	0.000236	CbGpPWpGaD
Brinzolamide—Hypersensitivity—Doxorubicin—hematologic cancer	1.12e-05	6.82e-05	CcSEcCtD
Brinzolamide—Vomiting—Methotrexate—hematologic cancer	1.12e-05	6.79e-05	CcSEcCtD
Brinzolamide—Rash—Methotrexate—hematologic cancer	1.11e-05	6.74e-05	CcSEcCtD
Brinzolamide—Dermatitis—Methotrexate—hematologic cancer	1.11e-05	6.73e-05	CcSEcCtD
Brinzolamide—CA14—Metabolism—PIK3CD—hematologic cancer	1.11e-05	0.000232	CbGpPWpGaD
Brinzolamide—Headache—Methotrexate—hematologic cancer	1.1e-05	6.69e-05	CcSEcCtD
Brinzolamide—Asthenia—Doxorubicin—hematologic cancer	1.09e-05	6.64e-05	CcSEcCtD
Brinzolamide—CA2—Metabolism—NCOR1—hematologic cancer	1.09e-05	0.000229	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—ALB—hematologic cancer	1.09e-05	0.000229	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GSTM1—hematologic cancer	1.09e-05	0.000229	CbGpPWpGaD
Brinzolamide—Dizziness—Epirubicin—hematologic cancer	1.09e-05	6.61e-05	CcSEcCtD
Brinzolamide—Pruritus—Doxorubicin—hematologic cancer	1.08e-05	6.55e-05	CcSEcCtD
Brinzolamide—CA1—Metabolism—ABCB1—hematologic cancer	1.08e-05	0.000226	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PIK3CD—hematologic cancer	1.08e-05	0.000226	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3CD—hematologic cancer	1.08e-05	0.000226	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—ALB—hematologic cancer	1.06e-05	0.000223	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—ALB—hematologic cancer	1.06e-05	0.000223	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CREBBP—hematologic cancer	1.06e-05	0.000223	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CREBBP—hematologic cancer	1.06e-05	0.000223	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CG—hematologic cancer	1.06e-05	0.000223	CbGpPWpGaD
Brinzolamide—Vomiting—Epirubicin—hematologic cancer	1.05e-05	6.36e-05	CcSEcCtD
Brinzolamide—CA1—Metabolism—NCOR1—hematologic cancer	1.05e-05	0.00022	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GSTM1—hematologic cancer	1.05e-05	0.00022	CbGpPWpGaD
Brinzolamide—Nausea—Methotrexate—hematologic cancer	1.05e-05	6.35e-05	CcSEcCtD
Brinzolamide—CA14—Metabolism—PIK3R1—hematologic cancer	1.04e-05	0.000219	CbGpPWpGaD
Brinzolamide—Diarrhoea—Doxorubicin—hematologic cancer	1.04e-05	6.33e-05	CcSEcCtD
Brinzolamide—Rash—Epirubicin—hematologic cancer	1.04e-05	6.31e-05	CcSEcCtD
Brinzolamide—Dermatitis—Epirubicin—hematologic cancer	1.04e-05	6.3e-05	CcSEcCtD
Brinzolamide—Headache—Epirubicin—hematologic cancer	1.03e-05	6.27e-05	CcSEcCtD
Brinzolamide—CA6—Metabolism—PIK3R1—hematologic cancer	1.02e-05	0.000214	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3R1—hematologic cancer	1.02e-05	0.000214	CbGpPWpGaD
Brinzolamide—Dizziness—Doxorubicin—hematologic cancer	1.01e-05	6.12e-05	CcSEcCtD
Brinzolamide—CA4—Metabolism—MTHFR—hematologic cancer	1.01e-05	0.000211	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PIK3CD—hematologic cancer	1.01e-05	0.000211	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3CD—hematologic cancer	1.01e-05	0.000211	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GSTP1—hematologic cancer	1e-05	0.00021	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—ALB—hematologic cancer	9.93e-06	0.000209	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—ALB—hematologic cancer	9.93e-06	0.000209	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	9.85e-06	0.000207	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CREBBP—hematologic cancer	9.83e-06	0.000206	CbGpPWpGaD
Brinzolamide—Nausea—Epirubicin—hematologic cancer	9.78e-06	5.94e-05	CcSEcCtD
Brinzolamide—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	9.72e-06	0.000204	CbGpPWpGaD
Brinzolamide—Vomiting—Doxorubicin—hematologic cancer	9.69e-06	5.88e-05	CcSEcCtD
Brinzolamide—CA2—Metabolism—MTHFR—hematologic cancer	9.64e-06	0.000203	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PIK3CB—hematologic cancer	9.64e-06	0.000202	CbGpPWpGaD
Brinzolamide—Rash—Doxorubicin—hematologic cancer	9.61e-06	5.83e-05	CcSEcCtD
Brinzolamide—Dermatitis—Doxorubicin—hematologic cancer	9.6e-06	5.83e-05	CcSEcCtD
Brinzolamide—Headache—Doxorubicin—hematologic cancer	9.54e-06	5.8e-05	CcSEcCtD
Brinzolamide—CA7—Metabolism—PIK3R1—hematologic cancer	9.5e-06	0.0002	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3R1—hematologic cancer	9.5e-06	0.0002	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ABCB1—hematologic cancer	9.47e-06	0.000199	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3CB—hematologic cancer	9.39e-06	0.000197	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PIK3CB—hematologic cancer	9.39e-06	0.000197	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CD—hematologic cancer	9.32e-06	0.000196	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—MTHFR—hematologic cancer	9.25e-06	0.000194	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GSTM1—hematologic cancer	9.2e-06	0.000193	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—NCOR1—hematologic cancer	9.2e-06	0.000193	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—ALB—hematologic cancer	9.2e-06	0.000193	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	9.05e-06	0.00019	CbGpPWpGaD
Brinzolamide—Nausea—Doxorubicin—hematologic cancer	9.05e-06	5.5e-05	CcSEcCtD
Brinzolamide—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	8.93e-06	0.000188	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3R1—hematologic cancer	8.8e-06	0.000185	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3CB—hematologic cancer	8.77e-06	0.000184	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PIK3CB—hematologic cancer	8.77e-06	0.000184	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CG—hematologic cancer	8.45e-06	0.000178	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PTEN—hematologic cancer	8.33e-06	0.000175	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—MTHFR—hematologic cancer	8.13e-06	0.000171	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CB—hematologic cancer	8.12e-06	0.000171	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PTEN—hematologic cancer	8.11e-06	0.00017	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PTEN—hematologic cancer	8.11e-06	0.00017	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CG—hematologic cancer	8.1e-06	0.00017	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—EP300—hematologic cancer	7.94e-06	0.000167	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CREBBP—hematologic cancer	7.84e-06	0.000165	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CG—hematologic cancer	7.77e-06	0.000163	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—EP300—hematologic cancer	7.74e-06	0.000163	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—EP300—hematologic cancer	7.74e-06	0.000163	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PTEN—hematologic cancer	7.57e-06	0.000159	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PTEN—hematologic cancer	7.57e-06	0.000159	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PHYH—hematologic cancer	7.55e-06	0.000159	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—FTCD—hematologic cancer	7.55e-06	0.000159	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GMPS—hematologic cancer	7.55e-06	0.000159	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CREBBP—hematologic cancer	7.51e-06	0.000158	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CD—hematologic cancer	7.43e-06	0.000156	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ALB—hematologic cancer	7.33e-06	0.000154	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—EP300—hematologic cancer	7.22e-06	0.000152	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—EP300—hematologic cancer	7.22e-06	0.000152	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CREBBP—hematologic cancer	7.2e-06	0.000151	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CD—hematologic cancer	7.12e-06	0.00015	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ALB—hematologic cancer	7.03e-06	0.000148	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PTEN—hematologic cancer	7.02e-06	0.000147	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3R1—hematologic cancer	7.02e-06	0.000147	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SMPD3—hematologic cancer	6.9e-06	0.000145	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CG—hematologic cancer	6.83e-06	0.000143	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CD—hematologic cancer	6.83e-06	0.000143	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ALB—hematologic cancer	6.74e-06	0.000142	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3R1—hematologic cancer	6.73e-06	0.000141	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—EP300—hematologic cancer	6.69e-06	0.000141	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CB—hematologic cancer	6.48e-06	0.000136	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3R1—hematologic cancer	6.45e-06	0.000135	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CREBBP—hematologic cancer	6.33e-06	0.000133	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CB—hematologic cancer	6.21e-06	0.00013	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—DCK—hematologic cancer	6.04e-06	0.000127	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—B3GAT1—hematologic cancer	6.04e-06	0.000127	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ASNS—hematologic cancer	6.04e-06	0.000127	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CD—hematologic cancer	6e-06	0.000126	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CB—hematologic cancer	5.95e-06	0.000125	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ALB—hematologic cancer	5.93e-06	0.000125	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PIK3CA—hematologic cancer	5.87e-06	0.000123	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3CA—hematologic cancer	5.72e-06	0.00012	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PIK3CA—hematologic cancer	5.72e-06	0.00012	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HDC—hematologic cancer	5.72e-06	0.00012	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3R1—hematologic cancer	5.67e-06	0.000119	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PTEN—hematologic cancer	5.6e-06	0.000118	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PTEN—hematologic cancer	5.37e-06	0.000113	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PIK3CA—hematologic cancer	5.34e-06	0.000112	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3CA—hematologic cancer	5.34e-06	0.000112	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—EP300—hematologic cancer	5.34e-06	0.000112	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CDA—hematologic cancer	5.23e-06	0.00011	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CB—hematologic cancer	5.23e-06	0.00011	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PTEN—hematologic cancer	5.14e-06	0.000108	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—EP300—hematologic cancer	5.12e-06	0.000107	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PC—hematologic cancer	5.04e-06	0.000106	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CA—hematologic cancer	4.95e-06	0.000104	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—EP300—hematologic cancer	4.91e-06	0.000103	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SLC35B2—hematologic cancer	4.86e-06	0.000102	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GBA—hematologic cancer	4.86e-06	0.000102	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—AKT1—hematologic cancer	4.8e-06	0.000101	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—AKT1—hematologic cancer	4.68e-06	9.82e-05	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—AKT1—hematologic cancer	4.68e-06	9.82e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PTEN—hematologic cancer	4.52e-06	9.5e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—MTAP—hematologic cancer	4.45e-06	9.35e-05	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—AKT1—hematologic cancer	4.37e-06	9.17e-05	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—AKT1—hematologic cancer	4.37e-06	9.17e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—EP300—hematologic cancer	4.31e-06	9.06e-05	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—AKT1—hematologic cancer	4.04e-06	8.5e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—FHL2—hematologic cancer	3.97e-06	8.33e-05	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CA—hematologic cancer	3.95e-06	8.29e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—AGRN—hematologic cancer	3.89e-06	8.17e-05	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CA—hematologic cancer	3.78e-06	7.95e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HMMR—hematologic cancer	3.69e-06	7.75e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—IDH2—hematologic cancer	3.69e-06	7.75e-05	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CA—hematologic cancer	3.63e-06	7.62e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.47e-06	7.28e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ACP5—hematologic cancer	3.37e-06	7.08e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CA9—hematologic cancer	3.37e-06	7.08e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.33e-06	6.99e-05	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—AKT1—hematologic cancer	3.23e-06	6.78e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CA—hematologic cancer	3.19e-06	6.7e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—IDH1—hematologic cancer	3.17e-06	6.66e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.13e-06	6.59e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.13e-06	6.59e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—TXN—hematologic cancer	3.13e-06	6.59e-05	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—AKT1—hematologic cancer	3.09e-06	6.5e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.07e-06	6.45e-05	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—AKT1—hematologic cancer	2.96e-06	6.23e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.95e-06	6.19e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.87e-06	6.02e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.87e-06	6.02e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.79e-06	5.87e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NUP98—hematologic cancer	2.71e-06	5.69e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.63e-06	5.52e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.63e-06	5.52e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NUP214—hematologic cancer	2.61e-06	5.48e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—AKT1—hematologic cancer	2.61e-06	5.48e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.56e-06	5.37e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—MTR—hematologic cancer	2.56e-06	5.37e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ENO2—hematologic cancer	2.51e-06	5.27e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.43e-06	5.11e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SDC1—hematologic cancer	2.38e-06	4.99e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CD44—hematologic cancer	2.02e-06	4.24e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NQO1—hematologic cancer	2.02e-06	4.24e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYCS—hematologic cancer	1.91e-06	4.02e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.9e-06	3.99e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.68e-06	3.54e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.59e-06	3.35e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.55e-06	3.25e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.55e-06	3.25e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.37e-06	2.87e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.15e-06	2.42e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.07e-06	2.24e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.01e-06	2.12e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ALB—hematologic cancer	9.98e-07	2.1e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3R1—hematologic cancer	9.54e-07	2.01e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CB—hematologic cancer	8.81e-07	1.85e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PTEN—hematologic cancer	7.61e-07	1.6e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—EP300—hematologic cancer	7.26e-07	1.53e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CA—hematologic cancer	5.37e-07	1.13e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—AKT1—hematologic cancer	4.39e-07	9.22e-06	CbGpPWpGaD
